Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm Malignant

Clinical trial condition

Neoplasm Malignant

Explore clinical trials studying Neoplasm Malignant. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm Malignant trial results

Completed

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

NCT01527929

Conditions: Neoplasm Malignant, Neoplasms
Locations: Investigational Site Number 056002 Brussels, Belgium

Investigational Site Number 056001 Ghent, Belgium

Investigational Site Number 380001 Milan, Italy

Investigational Site Number 528001 Rotterdam, Netherlands

View Trial Details

Completed

A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors

NCT01148615

Conditions: Neoplasm Malignant, Neoplasms
Locations: Sanofi-Aventis Investigational Site Number 156001 Guangzhou, China

View Trial Details

Active, Not Recruiting

EMPOWER 3: Improving Palliative Care Health Literacy and Utilization

NCT04733469

Conditions: Cancer, Neoplasm Malignant, Neoplasms
Locations: University Medical Center New Orleans, Louisiana, United States

Tulane University New Orleans, Louisiana, United States

View Trial Details

Active, Not Recruiting

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

NCT05818865

Conditions: Neoplasm Malignant, Neoplasms
Locations: Istitute Nazionale Tumori - Fondazione G. Pascale Naples, Italy

Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS Naples, Italy

View Trial Details

Active, Not Recruiting

A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer

NCT04987359

Conditions: Neoplasm Malignant, Neoplasms
Locations: Pennington Biomedical Research Center Baton Rouge, Louisiana, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

NCT04976634

Conditions: Neoplasm Malignant, Neoplasms
Locations: University of Arizona Cancer Center-University of Arizona Cancer Center - North Campus ( Site 5047) Tucson, Arizona, United States

City of Hope Comprehensive Cancer Center ( Site 5002) Duarte, California, United States

Cedars-Sinai Medical Center ( Site 5045) Los Angeles, California, United States

UCSF Medical Center at Mission Bay ( Site 5021) San Francisco, California, United States

View all 57 locations

View Trial Details

Active, Not Recruiting

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

NCT03845166

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: Exelixis Clinical Site #6 Duarte, California, United States

Exelixis Clinical Site #49 La Jolla, California, United States

Exelixis Clinical Site #7 Los Angeles, California, United States

Exelixis Clinical Site #84 Los Angeles, California, United States

View all 86 locations

View Trial Details